Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hu3S193 in advanced breast cancer
NCT01370239Phase 2Terminated
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of hu3S193 in breast cancer, sponsored by Instituto do Câncer do Estado de São Paulo. Started Nov 2013; status: terminated.
02
Drugs
hu3S193
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01370239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370239.